Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George S Mack

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Nature Biotechnology|February 11, 2009
Osiris seals billion-dollar deal with Genzyme for cell therapyGeorge S Mack
Nature Biotechnology|July 2, 2004
Genta sued over NDA withdrawalGeorge S Mack
Nature Biotechnology|October 8, 2004
Can complexity be commercialized?George S Mack
Nature Medicine|September 8, 2005
Revolt in BethesdaGeorge S Mack
Nature Biotechnology|March 11, 2008
Genzyme and Isis strike megadealGeorge S Mack
Nature Medicine|January 7, 2006
Low morale at US agency revives dormant scientist groupGeorge S Mack
Journal of the National Cancer Institute|October 19, 2006
Epigenetic cancer therapy makes headwayGeorge S Mack
Nature Biotechnology|October 11, 2008
CD20 blockers eye crowded rheumatology marketGeorge S Mack
Nature Biotechnology|December 9, 2010
To selectivity and beyondGeorge S Mack
Nature Biotechnology|December 13, 2006
Big pharma wants youGeorge S Mack
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Nature Biotechnology|February 11, 2009
Osiris seals billion-dollar deal with Genzyme for cell therapyGeorge S Mack
Nature Biotechnology|July 2, 2004
Genta sued over NDA withdrawalGeorge S Mack
Nature Biotechnology|October 8, 2004
Can complexity be commercialized?George S Mack
Nature Medicine|September 8, 2005
Revolt in BethesdaGeorge S Mack
Nature Biotechnology|March 11, 2008
Genzyme and Isis strike megadealGeorge S Mack
Nature Medicine|January 7, 2006
Low morale at US agency revives dormant scientist groupGeorge S Mack
Journal of the National Cancer Institute|October 19, 2006
Epigenetic cancer therapy makes headwayGeorge S Mack
Nature Biotechnology|October 11, 2008
CD20 blockers eye crowded rheumatology marketGeorge S Mack
Nature Biotechnology|December 9, 2010
To selectivity and beyondGeorge S Mack
Nature Biotechnology|December 13, 2006
Big pharma wants youGeorge S Mack
Pageof 3